Faron’s Post

This week is buzzing with three incredible conferences happening simultaneously and I am on my way to two of them, bringing my son to experience the impact of healthcare innovation in our life!!! 1. CX Healthcare in Carlsbad, CA: Focusing on the latest trends and innovations in patient experience and healthcare delivery. It's a fantastic opportunity to learn how we can better serve our patients and improve the overall healthcare journey. 2. BIO International Convention in San Diego, CA: The premier event for the biotechnology industry, bringing together industry leaders, researchers, and investors to discuss breakthroughs in biotech and life sciences. It's a great platform for fostering innovation and collaboration. 3. ASCO Annual Meeting in Chicago, IL: The go-to event for oncology professionals worldwide. It's all about advancing cancer care, sharing cutting-edge research, and improving patient outcomes through scientific excellence. Each of these conferences is vital in its own way, contributing to the betterment of healthcare, scientific progress, and patient care. The convergence of these events highlights the dynamic and interconnected nature of our industry. Let's seize these opportunities to learn, network, and drive meaningful change! 🚀 #Healthcare #Biotech #Oncology #Innovation #PatientCare

I'm pleased to announce that Accelerator Life Science Partners portfolio companies Automera, Proniras Corporation, and Kayothera will be represented at #JPMHC2025 - the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco this January. These companies exemplify innovation and are advancing science in critical therapeutic areas: Automera recently closed $16M in Series A funding to propel its pioneering autophagy-targeting chimera platform. Proniras Corporation has begun enrolling patients in its Phase 1 study of Tezampanel for the treatment of opioid withdrawal, marking an important step in addressing substance use disorders. Kayothera is progressing KAYO-1609, the first retinoid pathway inhibitor to enter IND-enabling studies, offering new hope in oncology. If you’ll be attending #JPM2025 (January 13–16) and would like to connect with these companies, please reach out via LinkedIn. Accelerator Life Science Partners remains steadfast in its commitment to advancing transformative solutions that address some of the most pressing challenges in healthcare. #jpmhc2025 #biotech #healthcareinnovation

2024: A Transformative Year at Athari BioSciences   From pioneering cancer therapeutics and reimagining vaccine delivery to empowering the next generation of STEMM leaders, Athari BioSciences is driving innovation that bridges science and social impact. Our work —through our CLIA-certified lab, groundbreaking research, and workforce development programs—represents a commitment to equitable, effective, and accessible healthcare solutions for all. We’re especially proud to announce the launch of Genomic Education Mentors & Scientists (GEMS), a nonprofit transforming genomic science education and mentoring future healthcare innovators (visit GEMS new site at https://lnkd.in/eh7MCT85 to learn more). Together, we’re addressing humanity’s greatest health challenges, bridging disparities, and building a brighter, healthier future. Ready to dive deeper? Explore how Athari BioSciences is shaping the future of healthcare in our latest blog, read more here: https://lnkd.in/e4X3UvA4 Susan Mitchell Athari BioSciences #InnovationInHealth #FutureSTEMMLeaders #GEMSMentors #BiotechForGood #CancerTherapeutics #VaccineInnovation #GlobalHealth #HealthEquity

Join the Conversation at EPPICON '24! Excited to announce the Thought Leader-led roundtables at EPPICON '24, where we'll dive into a wide range of current topics that matter most to the life sciences community. 🌐💡 But the discussion doesn’t end at the conference! We’re envisioning these conversations to continue well beyond through dynamic working groups and standalone satellite events. Be part of a movement that drives innovation and lasting impact in life sciences! 🌱 🔗 Register now using the code EARLY_BIRD_2024 to take advantage of our extended early bird discount. Don’t miss out—reserve your spot today! Contact Us: admin@eppicglobal.org Don’t miss out—this limited-time deal won’t last long! ⏳ #EPPICon2024 #HealthcareInnovation #HealthTech #USIndiaPartnership #Entrepreneurship #Innovation #LifeSciences #BiosercureAct #Data #AI #Commercialization #LLMs #Oncology #Hematology #Cancer #ClinicalTrials #Biopharma #Commercialization #Biotech #LLM #Regulatory #Compliance #Biopharma #Biotech #PatientCentricity #innovation #AI #RWE #Digital #Diversity #ClinicalTrials #Crossborder #Build #Biotech #CapitalEfficiency Avanish Mishra, Ph.D., Anurag Mairal, PhD (He/His),Neeraj Rama, Norma Goodwin, Hiranjith H, Swati Ranade, Ph.D., PMP

Immuno US 2024 is coming up fast! In the lead-up to the conference, we're presenting just some of our stand-out tracks that you should make sure to attend! On Day Two, don't miss out on Track 4: Designing Preclinical & Clinical Studies for Success. This session will dive deep into the strategies and innovations driving success in immunotherapy research—from early-stage study design to clinical trial execution. 🧪📊 Whether you're a researcher, biotech leader, or clinician, this track will provide valuable insights into optimizing study design, ensuring safety and efficacy, and accelerating the path to clinical breakthroughs 🚀 📅 When: October 28 - 29 2024 📍 Where: San Diego, CA Come along to network with top experts in the field! #OGImmuno #BiotechNews #HealthcareInnovation #CancerResearch #MedTech #PrecisionMedicine

Have a read of this important piece on Alzheimer's Disease by The Medicine Maker featuring our CSO Ashley Barnes and our good friend Chris Ward from STRATASTEM LIMITED. Ashley and Chris discuss our learnings from over a decade in the iPSC industry including the value of human iPSC technology and how an Alzheimer's Disease "clinical trial in a dish" model could transform drug discovery. #iPSCs #AlzheimersDisease #CTIAD #StemCells #PatientStratification

2024: A Year of Breakthroughs at VoxCell BioInnovation This year, we launched our first commercial products, gained recognition across the life sciences community, and kickstarted our first European partnership for tissue models. Key Highlights: 🌟 Funding Success: Closed an oversubscribed seed round! 🌟 Product Launch: Commercialized our proprietary Universal Bioinks™ and biopolymers like Gelatin Methacryloyl (GelMA), delivering cutting-edge solutions for academic and industry innovators. Explore our products and order directly on our website: 🌐 https://hubs.ly/Q0325b6p0 Plus, watch out for our upcoming tissue model product page—coming soon! 🌟 Strategic Partnership: Got down to work with our first T-cell therapy collaboration with German partners TheryCell GmbH and the NMI Natural and Medical Sciences Institute Institute. Learn more about the project here: 🌐 https://hubs.ly/Q0325b3w0 🌟 Leadership Growth: Welcomed Marie-Helene Raigneau to our Board of Directors, bringing decades of industry expertise. 🌟 Industry Recognition: - Winner of Collision Conf 2024 PITCH competition - Honored by Life Sciences BC as a "Company to Watch" - Finalist for Company of the Year – Growth Award at the 2024 Technology Impact Awards (TIAs) - Featured in Wiley Analytical Science Magazine: “Human-Like Cancer Tissue Models: Behind Canada’s First High-Resolution Bioprinter” Thank you to our team, partners, and supporters for an incredible year. Together, we’re transforming drug development and advancing life sciences innovation! #Biotech #3DBioprinting #LifeSciences #PreclinicalResearch #Oncology #TissueModels

We’re honored that Alcami and our CEO William Humphries were included in Investment Reports' new publication, 'The New Era of Life Sciences 2024'. Don’t miss this comprehensive and inspiring exploration of the advancements shaping healthcare and beyond. Download it here: https://lnkd.in/efABSXnm #Alcami #CEO #InvestmentReports #LifeSciences

How do Central Labs ensure reliability across global clinical trials? In our latest Q&A, Pagona Manika, shares insights into the critical role Central Labs play in ensuring consistency, managing biological samples, and advancing specialized testing. Here’s what Pagona covers: 🔹 How Central Labs ensure consistent, reliable data across multiple locations 🔹 Challenges Central Labs help overcome in sample management and storage 🔹 The importance of Central Labs in providing advanced, specialized testing 🔹 How Central Labs adapt to the complexity of biomarker analysis in personalized medicine and oncology trials Have more questions about clinical research? Drop them in the comments below and we’ll answer them in upcoming posts! 💬 #CentralLabs #ClinicalResearch #BiomarkerAnalysis #PersonalizedMedicine #YourQuestionsExpertAnswers #ClinicalTrials #HealthTech